MENU
+Compare
SYNB
ETF ticker: NYSE ARCA
AS OF
Jul 17 closing price
Price
$28.82
Change
-$0.12 (-0.41%)
Net Assets
5M

SYNB stock forecast, quote, news & analysis

The investment seeks long term capital appreciation... Show more

Category: #Health
SYNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SYNB with price predictions
Jul 18, 2025

SYNB saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for SYNB moved out of overbought territory on July 18, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 31 similar instances where the indicator exited the overbought zone. In of the 31 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Aroon Indicator for SYNB entered a downward trend on June 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 16, 2025. You may want to consider a long position or call options on SYNB as a result. In of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SYNB just turned positive on July 01, 2025. Looking at past instances where SYNB's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), ZOETIS (NYSE:ZTS), Regeneron Pharmaceuticals (NASDAQ:REGN), DuPont de Nemours (NYSE:DD), Biogen (NASDAQ:BIIB), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

The investment seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Market Cap

The average market capitalization across the Putnam BioRevolution ETF ETF is 213.28B. The market cap for tickers in the group ranges from 337.22M to 4.18T. NVDA holds the highest valuation in this group at 4.18T. The lowest valued company is RCKT at 337.22M.

High and low price notable news

The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 16%. For the same ETF, the average monthly price growth was 48%, and the average quarterly price growth was 80%. CRSP experienced the highest price growth at 15%, while TWST experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was -12%. For the same stocks of the ETF, the average monthly volume growth was -6% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 70
Price Growth Rating: 52
SMR Rating: 68
Profit Risk Rating: 67
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
SYNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Putnam ETF Trus100 FEDERAL STREET
Phone
6177601060
Web
N/A